Company Filing History:
1 out of 47 
1 out of 11 
1 out of 45 
Years Active: 2025
Title: Marco Cavaco: Innovator in Peptide Compounds
Introduction
Marco Cavaco is a notable inventor based in Lisbon, Portugal. He has made significant contributions to the field of medicinal chemistry, particularly in the development of peptide compounds aimed at reducing the side effects of CB1 receptor agonists. His innovative work has the potential to enhance therapeutic outcomes for patients.
Latest Patents
Marco Cavaco holds a patent for peptide compounds designed to mitigate the adverse effects associated with CB1 receptor agonists. The patent details compounds of formula (I) or their pharmaceutically acceptable salts, along with processes for their obtention and therapeutic indications. This invention represents a significant advancement in the field of pharmacology.
Career Highlights
Throughout his career, Marco has worked with prestigious institutions, including the University of Barcelona and Universitat Pompeu Fabra. His experience in these academic environments has allowed him to collaborate with leading researchers and contribute to groundbreaking studies in his field.
Collaborations
Marco has collaborated with esteemed colleagues such as Vicent Casadó Burillo and Estefania Moreno Guillen. These partnerships have fostered a rich exchange of ideas and have been instrumental in advancing their shared research goals.
Conclusion
Marco Cavaco's work in peptide compounds exemplifies the innovative spirit of modern science. His contributions are paving the way for new therapeutic strategies that could significantly improve patient care.